Shikiar Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-550
| Closed | -$349K | – | 83 |
|
|
2025
Q1 | $349K | Sell |
550
-220
| -29% | -$140K | 0.1% | 63 |
|
|
2024
Q4 | $548K | Sell |
770
-17
| -2% | -$12.1K | 0.15% | 57 |
|
|
2024
Q3 | $827K | Sell |
787
-12
| -2% | -$12.6K | 0.22% | 52 |
|
|
2024
Q2 | $840K | Sell |
799
-50
| -6% | -$52.6K | 0.22% | 47 |
|
|
2024
Q1 | $817K | Buy |
849
+11
| +1% | +$10.6K | 0.24% | 46 |
|
|
2023
Q4 | $736K | Sell |
838
-1,070
| -56% | -$940K | 0.23% | 42 |
|
|
2023
Q3 | $1.57M | Sell |
1,908
-358
| -16% | -$295K | 0.55% | 36 |
|
|
2023
Q2 | $1.63M | Sell |
2,266
-57
| -2% | -$41K | 0.52% | 36 |
|
|
2023
Q1 | $1.91M | Buy |
+2,323
| New | +$1.91M | 0.68% | 32 |
|
|
2022
Q3 | $1.64M | Sell |
2,382
-584
| -20% | -$402K | 0.66% | 33 |
|
|
2022
Q2 | $1.75M | Sell |
2,966
-653
| -18% | -$386K | 0.67% | 32 |
|
|
2022
Q1 | $2.53M | Buy |
3,619
+35
| +1% | +$24.4K | 0.72% | 29 |
|
|
2021
Q4 | $2.26M | Sell |
3,584
-343
| -9% | -$217K | 0.58% | 36 |
|
|
2021
Q3 | $2.38M | Buy |
3,927
+1,917
| +95% | +$1.16M | 0.67% | 35 |
|
|
2021
Q2 | $1.12M | Buy |
2,010
+393
| +24% | +$220K | 0.32% | 54 |
|
|
2021
Q1 | $765K | Sell |
1,617
-3,644
| -69% | -$1.72M | 0.26% | 56 |
|
|
2020
Q4 | $2.54M | Sell |
5,261
-7,009
| -57% | -$3.39M | 0.92% | 30 |
|
|
2020
Q3 | $6.87M | Buy |
12,270
+3,295
| +37% | +$1.84M | 2.64% | 10 |
|
|
2020
Q2 | $5.6M | Buy |
+8,975
| New | +$5.6M | 2.55% | 11 |
|